About

Anzor has assembled some of the world’s leading researchers in fibroblast growth factor technology to re-imagine breakthrough pharmaceuticals.

Our team is composed of leading scientists, clinicians and drug developers to lead of efforts to discover and apply our research findings into new pharmaceuticals to treat significant health needs.

Team - Management

Chris Adams

Founder and CEO
Pharmaceutical & device development for oncology, ophthalmology and metabolic disease. Over 1 million patients treated with invented products.

Dr. Moosa Mohammadi

Ph.D, Founder, Chief Technology Officer, Professor, Wenzhou Medical University School of Pharmaceutical Sciences, world expert in FGF technology. Co-inventor of the Sutent™ oncology drug.

Team - Advisors

Dr. Makoto Kuro

Ph.D, Professor, Center for
Molecular Medicine, Jichi Medical University, Japan. Expert in FGF technology and discoverer of the Klotho gene and longevity expert.

Dr. Orson Moe

MD. Professor of Internal Medicine and Physiology at UT Southwestern Medical Center at Dallas. Expert in metabolic disorders

Dr. Edward Skolnik

MD. Professor of Medicine, NYU Langone Medical Center

Dr. Aimin Xu

MD. Director, State Key Laboratory of Pharmaceutical Biotechnology, Hong Kong University

Omar A. Ibrahimi

MD. Ph.D. Medical Director, Connecticut Skin Institute, Director American Society for Dermatologic Surgery